Home
Glenmark Pharmaceuticals Ltd Share Price History
Glenmark Pharmaceuticals Ltd
NSE : 21 Feb, 2025
1300.8-48.2 (-3.6%)
Prev Close
1348.9
Open Price
1342.3
Bid Price (QTY)
-
Offer Price (QTY)
-
Volume
425017
Today's High / Low
1353.7 / 1290.1
52 WK High / Low
1830.9 / 883.0
Market Price of Glenmark Pharmaceuticals Ltd
1M
1Y
3Y
5Y
Monitoring Glenmark Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.
History Market Price
| Date | Price | Open | High | Low |
|---|
Returns Comparison
1W
1M
3M
6M
1Y
3Y
5Y
10Y
Growth Parameters
| Parameter |  2017 |
|---|---|
| Sales (Cr.) | NaN |
| Sales YoY Gr. | - |
| Adj EPS | 39.29 |
| YoY Gr. | - |
| Net Profit (Cr.) | 1109 |
| BVPS | 159.21 |
Key Financial Parameters
| Parameter | 2015 |
|---|---|
| Return on Capital Emp. % | 15.34 |
| Op. Profit Mgn % | 18.06 |
| Net Profit Mgn % | 3.9 |
| Debt to Equity % | 1.48 |
Latest Shareholding
Promoters Holdings Over Time
About Glenmark Pharmaceuticals Ltd
- Glenmark Pharmaceuticals Ltd was incorporated in November 18th, 1977.
- The Company is actively involved in the discovery of new molecules both NCEs (new chemical entity) and NBEs (new biological entity).
- It is engaged in the business of development, manufacture and marketing of pharmaceutical products both formulation and active pharmaceuticals ingredients to regulated and semi-regulated markets. The company has several molecules in various stages of pre-clinical and clinical development primarily focused in the areas of Oncology, Respiratory and Dermatology.
- Its branded generics business has a significant presence in markets across emerging economies including India.
- The company has 14 manufacturing facilities across US, India, Argentina, Czech Republic and Switzerland.
Popular Search
FAQs for Glenmark Pharmaceuticals Ltd Share Price History
What are the key events that typically impact Glenmark Pharmaceuticals Ltd's share price history?
Key events that impact Glenmark Pharmaceuticals Ltd’s share price history include quarterly earnings releases, product launches, leadership changes, economic policies, and geopolitical developments.
How do stock splits affect Glenmark Pharmaceuticals Ltd's share price history?
Stock splits reduce the nominal price of Glenmark Pharmaceuticals Ltd's shares by increasing the number of outstanding shares, which typically makes the stock more accessible to a broader range of investors. Although the total market value of the company remains unchanged after the split, the split can affect investor perception and liquidity, potentially influencing the share price in the longer term.
How do dividends impact the share price history of Glenmark Pharmaceuticals Ltd?
Dividends can influence Glenmark Pharmaceuticals Ltd's share price history by typically causing a temporary dip on the ex-dividend date, as the stock price often adjusts to reflect the dividend payout. Over time, the impact of dividends on the share price may be offset by the company's overall financial performance and market conditions.
How do corporate announcements affect Glenmark Pharmaceuticals Ltd’s share price history?
Corporate announcements such as mergers, acquisitions, or strategic shifts can lead to significant price changes. Any optimistic development news on Glenmark Pharmaceuticals Ltd generally boosts the company’s share price, whereas negative news can lead to a decline in share price.
How can I use technical analysis to understand Glenmark Pharmaceuticals Ltd’s share price history?
To understand Glenmark Pharmaceuticals Ltd’s share price history using technical analysis, examine charts for patterns such as trends, support, and resistance levels, and apply indicators like moving averages or Relative Strength Index (RSI) to gauge potential future movements. Analyze historical data to identify recurring trends and signals that might suggest how the share price could behave under similar conditions.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
